Latest Articles
6 women’s health developments in 2026 you need to know - The Female Lead | Substack
6 women’s health developments in 2026 you need to know The Female Lead | Substack
Published: June 9, 2026, 12:12 p.m.
South Portland hotel development displaces several businesses - newscentermaine.com
South Portland hotel development displaces several businesses newscentermaine.com
Published: June 5, 2026, 10:38 p.m.
Phenotypic and Functional Characterisation of Primary Endometriotic Stromal Cells for In Vitro Model Development - EMJ
Phenotypic and Functional Characterisation of Primary Endometriotic Stromal Cells for In Vitro Model Development EMJ
Published: April 30, 2026, 6:44 a.m.
Varun Dhawan reveals his 2-year-old daughter has Developmental Dysplasia of the Hip problem: All about... - Moneycontrol.com
Varun Dhawan reveals his 2-year-old daughter has Developmental Dysplasia of the Hip problem: All about... Moneycontrol.com
Published: March 30, 2026, 5:25 a.m.
Varun Dhawan reveals his 2-year-old daughter has Developmental Dysplasia of the Hip problem: All about... - moneycontrol.com
Varun Dhawan reveals his 2-year-old daughter has Developmental Dysplasia of the Hip problem: All about... moneycontrol.com
Published: March 30, 2026, 5:25 a.m.
Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism - Nature
Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism Nature
Published: March 26, 2026, 6:57 a.m.
TCF21 Identified as Regulator of EMT and Cytoskeletal Changes in Uterine Development and Endometriosis - geneonline.com
TCF21 Identified as Regulator of EMT and Cytoskeletal Changes in Uterine Development and Endometriosis geneonline.com
Published: March 5, 2026, 9:01 a.m.
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS - The Manila Times
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS The Manila Times
Published: March 3, 2026, 10:06 a.m.
Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours - The Manila Times
Step Pharma secures €2.5 million EIC grant to accelerate development of dencatistat for CTPS2 null gynaecological tumours The Manila Times
Published: Feb. 19, 2026, 12:12 p.m.
New 3D model reveals crucial interactions during early embryo development - MSN
New 3D model reveals crucial interactions during early embryo development MSN
Published: Jan. 14, 2026, 7:35 a.m.
Link copied to clipboard!